Antibiotic-resistant Neisseria meningitidis detected in the United States

Health authorities in Wisconsin have issued an alert regarding cases of invasive meningococcal disease caused by Neisseria meningitidis that are resistant to ciprofloxacin. Since June 2024, approximately 30 percent of recorded meningococcal cases in Wisconsin have shown resistance to this antibiotic, which is typically used to prevent infection in individuals who have had close contact with infected patients.

The Centers for Disease Control and Prevention (CDC) have noted that resistant strains of meningococcus, including those resistant to both ciprofloxacin and penicillin, have been detected in other parts of the United States. While officials clarify that this does not indicate a national outbreak, the presence of these variants in certain areas represents a significant proportion of registered cases.

Meningococcal disease can lead to meningitis or severe bloodstream infections and can progress rapidly. Transmission occurs through close, direct contact with respiratory or throat secretions, such as sharing water bottles, utensils, or living in close proximity with an infected person. Early diagnosis and treatment remain critical to reducing mortality and complications.